ESR1 and breast cancer: In breast cancer cell lines, Δ33 splice form expression ranges from approximately 6% to 11% in relation to total exon 33 expression (wild-type + Δ33 splice form) and no significant variation is observed according to estrogen receptor or differentiation status.